First Mercantile Trust’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
First Mercantile Trust's MRNA Position: Q3 2021 in Review
First Mercantile Trust reduced its Moderna (MRNA) stake by 54% in Q3 2021, selling an estimated $267K and leaving 626 shares worth $241K. The position accounts for 0.03% of the portfolio, ranked #346.
First Mercantile Trust first reported a position in MRNA in Q2 2020 and has held it in 6 quarters since. The position peaked at $317K in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.
- First Mercantile Trust held 626 shares of Moderna worth $241K as of Q3 2021.
- First Mercantile Trust sold 724 Moderna shares in Q3 2021, an estimated $267K.
- Moderna made up 0.03% of First Mercantile Trust's portfolio in Q3 2021, its #346 holding.
- First Mercantile Trust first reported a position in Moderna in Q2 2020 and has held it in 6 quarters since.
- First Mercantile Trust's Moderna position peaked at $317K in Q2 2021.
- 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.
Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.